共 71 篇文章
-
XTL6001再获EASD 2026两项口头报告：三靶点协同引领糖尿病与代谢疾病治疗新方向
XTL6001 Again Secures Two Oral Presentations at EASD 2026: Triple-Target Synergy Leads a New Direction in Diabetes and Metabolic Disease Therapy
넶15 2026-06-22 -
MT200605入选MDS 2026：全球首创TrkB激动剂亮相运动障碍国际学术年会
MT200605 Selected for Presentation at MDS 2026: First-in-Class Candidate to Debut at the Premier International Congress on Movement Disorders
넶8 2026-06-22 -
ADA 2026现场：XTL6001减重与肾病双壁报数据全球首秀
On Site at ADA 2026: Global Debut of Data from Two XTL6001 Posters in Weight Loss and Kidney Disease
넶5 2026-06-22 -
叶牛平市长莅临麦科奥特调研：加速创新药研发，助推生物医药产业高质量发展
Xi’an Mayor Ye Niuping Visited Micot: Accelerating Innovative Drug R\x26amp;D and Advancing High-Quality Biopharmaceutical Development
넶5 2026-06-22
新闻中心
奋斗为本、求是创新、协作共赢
